A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis

NCT00109408 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

673

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Methotrexate
DRUG: tocilizumab [RoActemra/Actemra]

Sponsor

Hoffmann-La Roche